(ALLO) Allogene Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Allogene Therapeutics | (ALLO) share price targets
Complete technical analysis of Allogene Therapeutics (ALLO) by charts plus indicators, forecast predictions and share price targets for Allogene Therapeutics (ALLO)
Allogene Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-28 View latest technical analysis
10 day averaged volume of Allogene Therapeutics is 4024060
| Date | Daily Closing Price | Open | High | Low | Volume |
| 28 Fri Jun 2024 | 2.33 | 2.44 | 2.45 | 2.27 | 0.891 times |
| 27 Thu Jun 2024 | 2.44 | 2.34 | 2.50 | 2.28 | 0.589 times |
| 26 Wed Jun 2024 | 2.34 | 2.39 | 2.44 | 2.23 | 0.745 times |
| 25 Tue Jun 2024 | 2.40 | 2.60 | 2.60 | 2.39 | 0.988 times |
| 24 Mon Jun 2024 | 2.61 | 2.55 | 2.67 | 2.55 | 1.071 times |
| 21 Fri Jun 2024 | 2.55 | 2.45 | 2.57 | 2.36 | 2.516 times |
| 20 Thu Jun 2024 | 2.44 | 2.26 | 2.47 | 2.21 | 1.462 times |
| 18 Tue Jun 2024 | 2.23 | 2.30 | 2.33 | 2.18 | 0.568 times |
| 18 Tue Jun 2024 | 2.23 | 2.30 | 2.33 | 2.18 | 0.568 times |
| 17 Mon Jun 2024 | 2.30 | 2.33 | 2.39 | 2.24 | 0.842 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2.3 as stoploss in an intra day buy trade for a target of 2.42. However, stock will show a bearish move below 2.3.
Share price targets for Allogene Therapeutics (ALLO)
| Target Type | Value |
| Downside Target | 2.18 |
| Downside Target | 2.23 |
| Downside Target | 2.31 |
| Upside Target | 2.39 |
| Upside Target | 2.57 |
| Upside Target | 2.67 |
| Upside Target | 2.70 |
| Upside Target | 3.47 |
| Upside Target | 3.65 |
| Upside Target | 4.12 |
| Upside Target | 4.45 |
| Upside Target | 5.38 |
| Upside Target | 5.78 |
Intraday share price targets for Allogene Therapeutics (ALLO)
| Target Type | Value |
| Downside Intraday Target | 2.15 |
| Downside Intraday Target | 1.97 |
| Upside Intraday Target | 2.59 |
| Upside Intraday Target | 2.85 |
| Upside Intraday Target | 2.41 |
Weekly technical analysis of Allogene Therapeutics (ALLO)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 28 Fri Jun 2024 | 2.33 | 2.55 | 2.67 | 2.23 | 0.942 times |
| 21 Fri Jun 2024 | 2.55 | 2.30 | 2.57 | 2.18 | 3.225 times |
| 18 Tue Jun 2024 | 2.23 | 2.33 | 2.39 | 2.18 | 0.475 times |
| 14 Fri Jun 2024 | 2.35 | 2.28 | 2.68 | 2.23 | 0.834 times |
| 07 Fri Jun 2024 | 2.32 | 2.53 | 2.68 | 2.24 | 0.998 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Allogene Therapeutics (ALLO)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 28 Fri Jun 2024 | 2.33 | 2.53 | 2.68 | 2.18 | 1.161 times |
| 31 Fri May 2024 | 2.50 | 2.78 | 3.65 | 2.31 | 1.407 times |
| 30 Tue Apr 2024 | 2.76 | 4.43 | 4.45 | 2.70 | 0.765 times |
| 28 Thu Mar 2024 | 4.47 | 4.94 | 5.78 | 4.12 | 1.137 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Allogene Therapeutics (ALLO)
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Allogene Therapeutics in short term but the buy signal is initial and weak.
Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Allogene Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Allogene Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.43 and Allogene Therapeutics (ALLO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Allogene Therapeutics in short term but the buy signal is initial and weak.
Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Allogene Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Allogene Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.43 and Allogene Therapeutics (ALLO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.